Cardiovascular disease prognosis
Pro Research Analysisby 
Searched over 200M research papers
Prognosis of Cardiovascular Disease: Key Predictors and Models
Fibroblast Growth Factor 21 (FGF21) and Coronary Artery Disease Prognosis
Elevated levels of fibroblast growth factor 21 (FGF21) have been shown to significantly predict poor outcomes in patients with coronary artery disease (CAD). A meta-analysis revealed that higher FGF21 levels are associated with an increased risk of major adverse cardiovascular events (MACE) and all-cause mortality in CAD patients. However, the role of FGF21 in heart failure (HF) prognosis remains unclear due to high heterogeneity and potential publication bias in the studies analyzed.
Stress Cardiac Magnetic Resonance Imaging (CMR) for CAD Prognosis
Stress cardiac magnetic resonance imaging (CMR) is a valuable tool for predicting cardiovascular outcomes in patients with known or suspected CAD. Studies indicate that patients with ischemia detected by stress CMR have a significantly higher incidence of myocardial infarction (MI) and cardiovascular death compared to those with negative CMR results. The annualized event rates for cardiovascular death and MI are markedly lower in patients with negative stress CMR, underscoring its prognostic utility.
Prognostic Models in Latin America and the Caribbean
In Latin America and the Caribbean (LAC), there is a lack of locally developed cardiovascular prognostic models. Existing models, such as the Framingham model, have been recalibrated for LAC populations but show varying degrees of accuracy. The American College of Cardiology/American Heart Association pooled equation demonstrated the best discrimination among the models assessed. However, the need for high-quality local cohorts to develop and validate region-specific models is critical.
Health Status and Heart Failure Prognosis Post-Myocardial Infarction
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is effective in predicting outcomes for heart failure patients post-acute myocardial infarction. Lower KCCQ scores are strongly associated with higher rates of cardiovascular mortality and hospitalization within one year. This tool can help clinicians quantify health status and stratify risk in heart failure patients.
Impact of Metabolic Syndrome on Cardiovascular Prognosis
Metabolic syndrome (MetS) significantly increases the risk of adverse cardiovascular events in patients with CVD. A meta-analysis found that MetS is associated with higher rates of all-cause death, cardiovascular death, MI, and stroke. Specific components of MetS, such as low high-density lipoprotein (HDL) and elevated fasting plasma glucose, further elevate these risks, highlighting the importance of managing these factors in CVD patients.
Machine Learning in Cardiovascular Risk Prediction
Machine learning (ML) techniques, particularly the AutoPrognosis framework, have shown promise in improving CVD risk prediction. An ML-based model using data from the UK Biobank outperformed traditional models like the Framingham score by incorporating a broader range of predictors, including non-traditional variables such as walking pace and self-reported health. This approach enhances predictive accuracy and can better serve diverse patient subgroups.
Cardiovascular Risk Prediction in India
In India, recalibrated Framingham models using local data from urban populations have been developed to improve CVD risk prediction. These models show variations in identifying high-risk individuals eligible for preventive treatments like statins. The study emphasizes the need for robust local cohorts to develop accurate prognostic models tailored to the Indian population.
Prognosis of Premature Coronary Artery Disease
Premature CAD, defined as CAD occurring before the age of 50, is associated with a high burden of modifiable risk factors such as smoking and hypertension. Despite these factors, many patients fail to achieve optimal control, leading to frequent ischemic recurrences and premature death. Effective management of these risk factors is crucial for improving long-term outcomes in this population.
Coronary Artery Disease and Transcatheter Aortic Valve Implantation (TAVI)
The presence of CAD does not significantly impact mid-term survival outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). This finding suggests that CAD should not be a deterrent in evaluating patients for TAVI, although individual risk factors should still be considered.
Coronary Vascular Dysfunction in Non-Obstructive CAD
Coronary vascular dysfunction, even in the absence of obstructive CAD, predicts adverse cardiovascular outcomes. Both endothelial-dependent and non-endothelial-dependent dysfunctions are associated with increased cardiovascular risk. This highlights the importance of assessing coronary vascular function in patients with normal or non-obstructive CAD to better predict and manage their prognosis.
Conclusion
The prognosis of cardiovascular disease is influenced by a variety of factors, including biomarkers like FGF21, imaging techniques like stress CMR, and comprehensive risk models. Advances in machine learning and the development of region-specific models are enhancing our ability to predict and manage cardiovascular risk. Effective management of modifiable risk factors remains a cornerstone in improving outcomes for patients with cardiovascular disease.
Sources and full results
Most relevant research papers on this topic